Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

Autor: Azzouzi, Abdel-Rahmène, Vincendeau, Sébastien, Barret, Eric, Cicco, Antony, Kleinclauss, François, van der Poel, Henk G, Stief, Christian G, Rassweiler, Jens, Salomon, Georg, Solsona, Eduardo, Alcaraz, Antonio, Tammela, Teuvo T, Rosario, Derek J, Gomez-Veiga, Francisco, Ahlgren, Göran, Benzaghou, Fawzi, Gaillac, Bertrand, Amzal, Billy, Debruyne, Frans M J, Fromont, Gaëlle, Gratzke, Christian, Emberton, Mark
Zdroj: In The Lancet Oncology February 2017 18(2):181-191
Databáze: ScienceDirect